Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season

Wkly Epidemiol Rec. 2017 Mar 17;92(11):117-28.
[Article in English, French]
No abstract available

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Antiviral Agents / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Geography, Medical
  • Global Health / statistics & numerical data
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza A Virus, H1N1 Subtype / immunology
  • Influenza A Virus, H3N2 Subtype / drug effects
  • Influenza A Virus, H3N2 Subtype / genetics
  • Influenza A Virus, H3N2 Subtype / immunology
  • Influenza B virus / drug effects
  • Influenza B virus / genetics
  • Influenza B virus / immunology
  • Influenza Vaccines / immunology*
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology*
  • Neuraminidase / antagonists & inhibitors
  • Seasons*
  • Zoonoses / epidemiology
  • Zoonoses / virology

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • Enzyme Inhibitors
  • Influenza Vaccines
  • Neuraminidase